Cidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin

Press/Media: Press / Media

PeriodJul 29 2019 → Jul 30 2019

Media coverage

14

Media coverage

  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletPipelineReview
    CountrySpain
    Date7/30/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    CountryJordan
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletSPi World News
    CountryUnited Kingdom
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletNasdaq
    CountryUnited States
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletYahoo! Finance
    CountryUnited States
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletAPNews.com
    CountryUnited States
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletMarketScreener.com
    CountryUnited States
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletCrwe World
    CountryUnited States
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletIndia Pharma News
    CountryIndia
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletBiotechgate
    CountrySwitzerland
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletGlobeNewswire
    CountryUnited States
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date7/29/19
    PersonsGEORGE THOMPSONIII
  • TitleCidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
    Media name/outletPressReleasePoint
    CountryIndia
    Date7/29/19
    PersonsGEORGE THOMPSONIII